News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boston Scientific Corporation (BSX) Gains China OK for Non-Drug Asthma Treatment


10/25/2013 3:37:41 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

October 25, 2013 -- Boston Scientific received CFDA approval for the AlairĀ® Bronchial Thermoplasty System, a medical device that treats severe asthma when drugs do not control attacks. Using the Alair System, Bronchial Thermoplasty applies radiofrequency to produce mild heat that reduces excessive smooth muscle tissue in the airways. This lowers the constriction of airways during an attack and makes attacks both less frequent and less severe. More details....

Stock Symbol: (NYSE: BSX)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   
Asthma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES